Sentences with phrase «with other cancer»

The most common cancer types were breast (8), lung (3) and prostate (3), with other cancer types including endometrial, lymphoma, ovarian, rectal and renal cancer.

Once the plan is launched, we can quickly compare with other cancer insurance plans.

You may also want to discuss using natural supplements like NHV ES Clear, Milk Thistle, PetOmega 3, BK Detox, and Turmeric in conjunction with other cancer treatments to help support the body and immune system.

However, there is a new cancer remedy that is free, has nearly no side effects, and can be blended with other cancer treatments.

Fasting is a powerful healing strategy, not only does it provide great benefits on its own, but it actually makes for a great combination with other cancer healing modalities.

Vyriad's product pipeline encompasses multiple clinical - and preclinical - stage programs that target a broad range of cancer indications as well as programs that pair the company's oncolytic viruses with other cancer immunotherapy modalities, traditional cancer therapy, and newer targeted therapies.

This type of treatment is often used along with other cancer treatments, including radiation therapy or surgery to remove a cancerous tumor.

Radiation is often used in conjunction with other cancer treatments such as surgery, chemotherapy or bone marrow transplant, depending on each child's specific diagnosis.

A Phase 1b / 2 Open - Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies

The researchers» study also found that, compared with patients with other cancer types, patients with breast cancer were 3.7 times less likely to develop PTSD at six months, but not at four years.

The gene has also been shown to synergize with other cancer treatments.

Although insufficient on its own to trigger leukemia, f - circM9 appears to work together with other cancer - promoting signals (such as the MLL - AF9 fusion protein) to cause disease.

«These studies provide promising evidence that autophagy blockade can be achieved, and that combining autophagy inhibitors with other cancer therapies in very sick patients can be accomplished safely in most cases.

Kelley also worries about the fundamental complexity of vaccines, which makes it harder to achieve full medical potential than with other cancer therapies, he feels.

The same rings true when immunotherapy is paired with other cancer treatments like chemotherapy, for example.

Triple negative breast cancer is especially hard to treat because it lacks the receptors, such as the estrogen receptor, targeted with other cancer drugs.

The two companies plan to develop drugs to fight multiple cancer types, either alone or in combination with their other cancer treatments.

More researchers joined the fray, keen to test CAR - T therapy in patients with other cancers.

More recently, HCQ has shown promise in treating pancreatic cancer patients in ongoing clinical trials; however, its tolerability and effectiveness to stop autophagy in humans with other cancers has not been shown before.

People with other cancers — especially if they're older or have many other health problems — should also be vigilant for heart symptoms if they receive anthracyclines or trastuzumab, Chen said.

No safety concerns were identified in previous studies of pemetrexed and gemcitabine for treatment in children with other cancers.

Those who work with other cancers certainly haven't been so lucky.

It is a different story with other cancers, such as leukaemia, as there is the possibility that the cancer will spread undetected to the ovary, and on reimplantion cancerous tissue would be returned to the body.»

And, as with other cancers, larger cancers and those that have invaded the lymph nodes are more likely to be fatal.

If a tumor is already present, curcumin, as it does with other cancers, can keep it from spreading to other organs.

Dogs with hemangiosarcoma were 8 (small dogs) to 9 (large dogs) times more likely to develop hemoabdomen, compared to dogs with other cancers.

Blood transfusion was also more likely to be performed in both small and large dogs diagnosed with hemangiosarcoma compared to those with other cancers or benign disease.

Periodically, clinical trials are available for pets with other cancers as well.

Not exact matches

Tough Mudder isn't curing cancer, but they do feel they're making the world a slightly better place by helping people lead more active lives and connect with each other.

Research on green tea consumption in people with other forms of cancer has been too limited to say whether it's beneficial.

In the most recent of these reports (in the latest issue of Science), Dr. Jennifer Wargo, a surgeon and research scientist at M.D. Anderson, along with several dozen colleagues at other institutions, reveal that the composition of a patient's gut microbiota can significantly influence whether he or she responds to an immune checkpoint inhibitor — the type of cancer immunotherapy that releases the emergency brakes in the car analogy above.

The wrong set of changes to a single cell's genetic code, combined with other system breakdowns, can lead to cancer.

«HEPs listen hard to others and do all they can to grasp their emotional state and needs, whether it is a friend who has just been diagnosed with cancer or a spouse who is upset at them for working late yet again,» he writes, adding, «but listening is never enough.

A growing collection of research suggests that excess added sugar in the diet has strong links to cancer, and is already strongly tied with obesity, diabetes, and heart and other deadly cardiovascular diseases.

It is partnering with Georgetown Lombardi Cancer Center and others on research.

Two Perth - based resources companies are planning to switch sectors with the acquisition of cancer - based biotechnology firms, with one planning a backdoor listing and the other seeking support for an IPO.

Along with the introduction of other new drugs such as psoriasis treatment Cosentyx, Novartis is hoping that Kymriah will help turn things around after the patent protections expired for its Gleevec cancer drug and Gilenya multiple sclerosis treatment, opening the door to cheaper competitors.

And they now have the option, in terms of self - managing their care with their own primary care physician, to be more on the lookout for any other symptoms of cancer, so we can catch it early.»

Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).

Bristol - Myers emphasized Opdivo's other successes and ongoing studies evaluating its effectiveness in combination with the company's other cancer drugs.

There's still much more work to do with other types of cancer, but the overall trajectory is pointing in the right direction.

They decided to combine their wish to help others with their desire for laid - back footwear, and they chose to place their focus on causes related to pediatric cancer.

Other gifts include a Christmas tree sent to a couple living in a hotel because their home was destroyed in a tornado, a travel care package sent to a woman with cancer who had to travel across the country every three weeks for treatment, and a package of new toys sent to a little girl whose own were destroyed in a fire.

That debate, in case you're wondering, continues still, with some contending that the practice has led to cancer and other bad health outcomes.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.

Effective PARP inhibitors are particularly sought after by drugmakers because of their potential to be used in combination with other types of cancer treatments to create new breakthroughs in treatments.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

The Harvard Business School Kraft Precision Medicine Accelerator is working with the MMRF and other cancer partners to harness the potential of master protocols in precision oncology.

The drugs have led to major advances in treating cancer and other diseases, but often come with a massive price tag.